IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX - Nasdaq - BMG4690M1010 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to IBEX. IBEX was compared to 82 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making IBEX a very profitable company, without any liquidiy or solvency issues. IBEX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes IBEX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
In the past 5 years IBEX has always been profitable.
Each year in the past 5 years IBEX had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 11.02%, IBEX belongs to the best of the industry, outperforming 86.08% of the companies in the same industry.
IBEX has a Return On Equity of 19.73%. This is amongst the best in the industry. IBEX outperforms 82.28% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.15%, IBEX belongs to the top of the industry, outperforming 91.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.02% | ||
| ROE | 19.73% | ||
| ROIC | 15.15% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.57%, IBEX is in the better half of the industry, outperforming 69.62% of the companies in the same industry.
In the last couple of years the Profit Margin of IBEX has grown nicely.
With a decent Operating Margin value of 8.39%, IBEX is doing good in the industry, outperforming 67.09% of the companies in the same industry.
IBEX's Operating Margin has improved in the last couple of years.
IBEX has a Gross Margin (30.23%) which is in line with its industry peers.
IBEX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.39% | ||
| PM (TTM) | 6.57% | ||
| GM | 30.23% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IBEX is still creating some value.
IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.22 indicates that IBEX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.22, IBEX is doing good in the industry, outperforming 63.29% of the companies in the same industry.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.06, IBEX belongs to the best of the industry, outperforming 91.14% of the companies in the same industry.
IBEX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IBEX has a better Debt to Equity ratio (0.00) than 86.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 4.22 |
ROIC/WACC1.36
WACC11.15%
2.3 Liquidity
A Current Ratio of 2.42 indicates that IBEX has no problem at all paying its short term obligations.
The Current ratio of IBEX (2.42) is better than 75.95% of its industry peers.
A Quick Ratio of 2.42 indicates that IBEX has no problem at all paying its short term obligations.
IBEX's Quick ratio of 2.42 is fine compared to the rest of the industry. IBEX outperforms 75.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.42 | ||
| Quick Ratio | 2.42 |
3. Growth
3.1 Past
IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.46%, which is quite good.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.59% yearly.
Looking at the last year, IBEX shows a decrease in Revenue. The Revenue has decreased by -1.20% in the last year.
The Revenue has been growing slightly by 6.66% on average over the past years.
EPS 1Y (TTM)15.46%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%30%
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%4.1%
3.2 Future
IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.13% yearly.
The Revenue is expected to grow by 3.80% on average over the next years.
EPS Next Y15.95%
EPS Next 2Y13.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y3.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IBEX is valuated reasonably with a Price/Earnings ratio of 9.86.
Based on the Price/Earnings ratio, IBEX is valued cheaper than 93.67% of the companies in the same industry.
IBEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.51.
With a Price/Forward Earnings ratio of 8.14, the valuation of IBEX can be described as very reasonable.
94.94% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
IBEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 93.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 8.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 92.41% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 88.61% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.08 | ||
| EV/EBITDA | 5.06 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
IBEX's earnings are expected to grow with 13.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)0.39
EPS Next 2Y13.13%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IBEX LTD
NASDAQ:IBEX (1/30/2025, 4:03:36 PM)
After market: 22.09 0 (0%)22.09
-0.23 (-1.03%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners81.83%
Inst Owner Change0.29%
Ins Owners12.48%
Ins Owner Change-126.86%
Market Cap370.23M
Analysts82.5
Price Target23.97 (8.51%)
Short Float %0.88%
Short Ratio0.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.82%
Min EPS beat(2)7.33%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)8.33%
Min EPS beat(4)-14.31%
Max EPS beat(4)31.98%
EPS beat(8)6
Avg EPS beat(8)13.47%
EPS beat(12)8
Avg EPS beat(12)12.12%
EPS beat(16)11
Avg EPS beat(16)13.1%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.58%
Revenue beat(8)1
Avg Revenue beat(8)-2.86%
Revenue beat(12)3
Avg Revenue beat(12)-1.62%
Revenue beat(16)3
Avg Revenue beat(16)-2.07%
PT rev (1m)0%
PT rev (3m)9.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.44%
EPS NY rev (1m)0%
EPS NY rev (3m)11.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 8.14 | ||
| P/S | 0.72 | ||
| P/FCF | 15.08 | ||
| P/OCF | 10.58 | ||
| P/B | 2.16 | ||
| P/tB | 2.32 | ||
| EV/EBITDA | 5.06 |
EPS(TTM)2.24
EY10.14%
EPS(NY)2.71
Fwd EY12.28%
FCF(TTM)1.46
FCFY6.63%
OCF(TTM)2.09
OCFY9.45%
SpS30.65
BVpS10.21
TBVpS9.5
PEG (NY)0.62
PEG (5Y)0.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.02% | ||
| ROE | 19.73% | ||
| ROCE | 18.87% | ||
| ROIC | 15.15% | ||
| ROICexc | 20.83% | ||
| ROICexgc | 22.42% | ||
| OM | 8.39% | ||
| PM (TTM) | 6.57% | ||
| GM | 30.23% | ||
| FCFM | 4.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 55.53% | ||
| Cap/Sales | 2.03% | ||
| Interest Coverage | 74.86 | ||
| Cash Conversion | 56.5% | ||
| Profit Quality | 72.71% | ||
| Current Ratio | 2.42 | ||
| Quick Ratio | 2.42 | ||
| Altman-Z | 4.22 |
F-Score6
WACC11.15%
ROIC/WACC1.36
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.46%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%30%
EPS Next Y15.95%
EPS Next 2Y13.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%4.1%
Revenue Next Year3.3%
Revenue Next 2Y3.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.83%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year83.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y69.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.54%
OCF growth 3Y30.7%
OCF growth 5Y74.8%